Genitourinary Cancers | Specialty

Integrating Molecular Testing Into Urology Practices

February 13th 2015

Biomarkers for Aiding Risk Stratification and Treatment Decisions

February 13th 2015

Follow-up Biomarker Testing in Prostate Cancer

February 13th 2015

Strategies for Using Biomarkers in Prostate Cancer

February 13th 2015

Sequencing VEGFR-Targeted and mTOR-Targeted Therapy in Advanced Renal Cell Carcinoma

February 2nd 2015

With 8 therapies approved by the US Food and Drug Administration (FDA) for the treatment of patients with advanced renal cell carcinoma (RCC), practitioners are faced with the challenge of selecting the most appropriate therapies for their patients within this crowded therapeutic landscape.

Dr. Cookson on Ideal Bladder Cancer Biomarkers

January 13th 2015

No one biomarker is effective for all types of bladder cancer, says Michael Cookson, MD, a professor and chairman of the Department of Urology at the University of Oklahoma College of Medicine.

Collaboration in Groups Improves Care, Averts Pay Cuts

December 24th 2014

Urologists who are members of LUGPA are doing the right thing by being part of large group practices.

Multiparametric MRI Could Reduce Overdetection and Overtreatment in Prostate Cancer

December 20th 2014

The use of multiparametric MRI in diagnosing and treating prostate cancer was explored in November during a continuing medical education course offered at the annual meeting of LUGPA

Final Thoughts on Improving Prostate Cancer Care

December 17th 2014

Integrating a Medical Oncologist Into Urology Practices

December 17th 2014

Combination Strategies Explored in CRPC

December 17th 2014

Integrating Radium-223 Into Clinical Practice

December 17th 2014

Providing Optimal Care for Prostate Cancer

December 17th 2014

Data: The New Currency in Healthcare Improvement

December 17th 2014

Integrating Dispensing Pharmacy Services Into a Urology Group

December 17th 2014

Multiparametric MRI Biopsies: Poised for Widespread Adoption?

December 17th 2014

Multiparametric MRI for Detecting Prostate Cancer

December 17th 2014

Large Groups Are Positioned Well in New Healthcare Arena

December 17th 2014

While Laszewski said the Affordable Care Act (ACA), which is driving many of the changes, may end up being altered, he doesn't expect the program to be disbanded due to the political shift in legislative power.

Preparing for the Future

December 15th 2014

In attending the Society of Urologic Oncology's annual meeting in Bethesda in early December, I was struck by the number of presentations focusing sharply on the burgeoning fields of biomolecular markers and immunotherapy and their application to urologic oncology.

To Succeed, Urology Practices Must Change With the Times

November 25th 2014

Entrepreneur James Feldman, chief innovation officer of the Chicago-based company Shift Happens!, calls himself "a doctor for business."